Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Combining scalp acupoint catgut embedding with 5% minoxidil may help treat male pattern baldness.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Topical ruxolitinib quickly improves non-segmental vitiligo.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Alpha-blockers are recommended first for recent CP/CPPS, while antimicrobials are not advised for long-term cases.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

CTP-543 is generally safe for treating alopecia areata.

Shaving, erythromycin cream, and clotrimazole powder effectively treated the bad odor and rough hair.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

The lotion and shampoo effectively treated scalp seborrheic dermatitis.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

The new delivery method for dutasteride is more effective and has fewer side effects.